GATA6 and cancer: Although recent studies demonstrated that GATA6 expression by RNA-seq, ISH and IHC with digital assistance distinguished transcriptomic classical and basal-like subtype in advanced PDAC10,13, it is difficult to implement these technologies into clinical practice because it is costly, time-consuming and is limited to access only in high-volume cancer centers.